Tamaki, J. http://orcid.org/0000-0003-3930-9729
,
Iki, M.
Sato, Y.
Kajita, E.
Nishino, H.
Akiba, T.
Matsumoto, T.
Kagamimori, S.
Funding for this research was provided by:
Japan Milk Promotion Board
the Japan Dairy Council
the Japanese Society for the Promotion of Science (B #10470114, 1998–2000, B #14370147, 2002–2003, B #18390201, 2006-2008, C#18590619, 2006-9, B# 23390180, 2011-13, C#23590824, 2011-13, #23659362, 2011-12)
the Research Society for Metabolic Bone Diseases
the Japan Dairy Association
Article History
Received: 2 November 2016
Accepted: 12 February 2017
First Online: 27 February 2017
Compliance with ethical standards
: The study protocol was approved by the Ethics Committee of the Kinki University School of Medicine. Written informed consent regarding all study procedures was obtained from each participant before baseline and follow-up studies.
: Grant support to MI, consulting fee to MT, and measurement of 25-hydroxyvitamin D were provided by Roche Diagnostics (Rotkreuz, Switzerland). The funding source did not play any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.